A detailed history of Custom Index Systems, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Custom Index Systems, LLC holds 941 shares of BIIB stock, worth $184,087. This represents 0.13% of its overall portfolio holdings.

Number of Shares
941
Holding current value
$184,087
% of portfolio
0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$190.52 - $236.72 $179,279 - $222,753
941 New
941 $218 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $28.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Custom Index Systems, LLC Portfolio

Follow Custom Index Systems, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Custom Index Systems, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Custom Index Systems, LLC with notifications on news.